STRYKER CORP (SYK)

332 0.46 (0.14%)

As of 2026-04-02 18:38:22 EST

Stryker Corporation is an American multinational medical technologies corporation based in Portage, Michigan, United States. The company's products are used for medical surgery and neurotechnology (60% of 2024 revenues), which include surgical equipment, patient and caregiver safety technologies, endoscopy systems, and patient handling, emergency medical equipment, and intensive care disposable products, as well as neurosurgical, neurovascular and oral and maxillofacial surgery implant products; and orthopedic surgery (40% of 2024 revenues), which includes implants used in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries. Stryker's products are sold in over 75 countries and are used by 150 million patients annually. In 2024, 75% of the company's revenues came from the United States.

Traded asNYSE: SYK
ISINUS8636671013
CIK0000310764
LEI5493002F0SC4JTBU5137
EIN381239739
SectorHealth technology
IndustrySurgical & Medical Instruments & Apparatus
CEOKevin A. Lobo
Employees53,000
Fiscal Year End1231
Address1941 STRYKER WAY, PORTAGE, MI, 49002
Phone2693852600
Websitehttp://stryker.com
Stock Quotes
trading_symbolregistrant_nametimepricechangepercentage_change
SYKSTRYKER CORP2026-04-02 18:38:223320.460.14
This is a preview of the latest data. Subscribe to access the full data.
Company Information
trading_symbolcentral_index_keyregistrant_nameisin_numberlei_numberein_numberexchangesic_codesic_descriptionfiscal_year_endstate_of_incorporationaddress_streetaddress_cityaddress_stateaddress_zip_codeaddress_countryaddress_country_codephone_numbermailing_addressbusiness_addressformer_nameindustryfounding_datechief_executive_officernumber_of_employeeswebsitemarket_capshares_issuedshares_outstandingdescriptionupdate_time
SYK0000310764STRYKER CORPUS86366710135493002F0SC4JTBU5137381239739NYSE3841Surgical & Medical Instruments & Apparatus1231MI1941 STRYKER WAYPORTAGEMI49002UNITED STATESUS26938526001941 STRYKER WAY, PORTAGE, MI, 490021941 STRYKER WAY, PORTAGE, MI, 49002—Health technology1941Kevin A. Lobo53,000http://stryker.com144,306,436,547—382,688,675Stryker Corporation is an American multinational medical technologies corporation based in Portage, Michigan, United States. The company's products are used for medical surgery and neurotechnology (60% of 2024 revenues), which include surgical equipment, patient and caregiver safety technologies, endoscopy systems, and patient handling, emergency medical equipment, and intensive care disposable products, as well as neurosurgical, neurovascular and oral and maxillofacial surgery implant products; and orthopedic surgery (40% of 2024 revenues), which includes implants used in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries. Stryker's products are sold in over 75 countries and are used by 150 million patients annually. In 2024, 75% of the company's revenues came from the United States.2026-04-02 15:11:26
This is a preview of the latest data. Subscribe to access the full data.
SYK Stock Price (End-of-Day)
This is a preview of the latest data. Subscribe to access the full data.
SYK Stock Price (1-Minute)
This is a preview of the latest data. Subscribe to access the full data.
Market Cap
Fiscal YearMarket CapChange In Market CapPercentage Change In Market CapShares OutstandingChange In Shares OutstandingPercentage Change In Shares Outstanding
2025144,306,436,54721,158,537,99317.1814382,688,6751,109,5520.2908
2024123,147,898,55413,424,995,96512.2354381,579,1231,315,0870.3458
2023109,722,902,58938,757,739,73654.6152380,264,0361,432,7870.3782
This is a preview of the latest data. Subscribe to access the full data.
Executive Compensation
Executive NameExecutive PositionFiscal YearSalaryBonusStock AwardsIncentive Plan CompensationOther CompensationTotal Compensation
J. Andrew PierceGroup President2025792,500—2,685,078754,148188,0816,323,107
Preston W. WellsVice President, Chief Financial Officer2025653,431—1,841,377514,558103,3394,410,422
Kevin A. LoboChair, Chief Executive Officer, President20251,491,667—9,764,1362,250,000974,91121,401,495
Spencer S. StilesGroup President2025792,500—2,685,078760,000188,0816,328,959
Viju S. MenonGroup President2025675,000—1,647,444578,000167,4764,235,809
This is a preview of the latest data. Subscribe to access the full data.
Employee Count
Fiscal YearEmployee Count
202556,000
202453,000
202352,000
This is a preview of the latest data. Subscribe to access the full data.
Income Statements
Fiscal Year202520242023
Revenue25,116,000,00022,595,000,00020,498,000,000
Cost Of Revenue9,051,000,0008,155,000,0007,440,000,000
Gross Profit16,065,000,00014,440,000,00013,058,000,000
Research And Development Expenses1,623,000,0001,466,000,0001,388,000,000
General And Administrative Expenses8,651,000,0007,685,000,0007,129,000,000
Operating Expenses11,176,000,00010,751,000,0009,170,000,000
Operating Income4,889,000,0003,689,000,0003,888,000,000
Net Income3,246,000,0002,993,000,0003,165,000,000
Earnings Per Share Basic8.497.868.34
Earnings Per Share Diluted8.47.768.25
Weighted Average Shares Outstanding Basic382,200,000381,000,000379,600,000
Weighted Average Shares Outstanding Diluted386,500,000385,600,000383,700,000
This is a preview of the latest data. Subscribe to access the full data.
Balance Sheet Statements
Fiscal Year202520242023
Cash And Cash Equivalents4,011,000,0003,652,000,0002,971,000,000
Marketable Securities Current89,000,00091,000,00082,000,000
Accounts Receivable4,039,000,0003,987,000,0003,765,000,000
Inventories5,310,000,0004,774,000,0004,843,000,000
Non Trade Receivables———
Other Assets Current1,306,000,0001,593,000,000857,000,000
Total Assets Current14,755,000,00014,847,000,00012,518,000,000
Marketable Securities Non Current———
Property Plant And Equipment3,876,000,0003,448,000,0003,215,000,000
Other Assets Non Current3,143,000,0002,684,000,0002,673,000,000
Total Assets Non Current33,089,000,00028,124,000,00027,394,000,000
Total Assets47,844,000,00042,971,000,00039,912,000,000
Accounts Payable1,799,000,0001,679,000,0001,517,000,000
Deferred Revenue———
Short Term Debt1,000,000,0001,409,000,0002,094,000,000
Other Liabilities Current2,645,000,0002,266,000,0001,928,000,000
Total Liabilities Current7,794,000,0007,616,000,0007,921,000,000
Long Term Debt14,859,000,00012,188,000,00010,901,000,000
Other Liabilities Non Current2,369,000,0002,184,000,0001,930,000,000
Total Liabilities Non Current17,630,000,00014,721,000,00013,398,000,000
Total Liabilities25,424,000,00022,337,000,00021,319,000,000
Common Stock38,000,00038,000,00038,000,000
Retained Earnings20,472,000,00018,528,000,00016,771,000,000
Accumulated Other Comprehensive Income-687,000,000-293,000,000-416,000,000
Total Shareholders Equity22,420,000,00020,634,000,00018,593,000,000
This is a preview of the latest data. Subscribe to access the full data.
Cash Flow Statements
Fiscal Year202520242023
Depreciation And Amortization732,000,000623,000,000635,000,000
Share Based Compensation Expense243,000,000229,000,000205,000,000
Other Non Cash Income Expense———
Change In Accounts Receivable-127,000,000321,000,000175,000,000
Change In Inventories297,000,000206,000,000797,000,000
Change In Non Trade Receivables———
Change In Other Assets———
Change In Accounts Payable94,000,000192,000,00077,000,000
Change In Other Liabilities470,000,000306,000,000134,000,000
Cash From Operating Activities5,044,000,0004,242,000,0003,711,000,000
Purchases Of Marketable Securities—58,000,00052,000,000
Sales Of Marketable Securities—49,000,00054,000,000
Acquisition Of Property Plant And Equipment761,000,000755,000,000575,000,000
Acquisition Of Business4,960,000,0001,628,000,000390,000,000
Other Investing Activities60,000,000-43,000,000-1,000,000
Cash From Investing Activities-4,866,000,000-3,000,000,000-962,000,000
Tax Withholding For Share Based Compensation149,000,000195,000,000155,000,000
Payments Of Dividends1,284,000,0001,219,000,0001,139,000,000
Issuance Of Common Stock———
Repurchase Of Common Stock———
Issuance Of Long Term Debt2,979,000,0003,011,000,0001,241,000,000
Repayment Of Long Term Debt1,400,000,0002,039,000,0002,058,000,000
Other Financing Activities-33,000,000-51,000,000-23,000,000
Cash From Financing Activities113,000,000-525,000,000-1,594,000,000
Change In Cash359,000,000681,000,0001,127,000,000
Cash At End Of Period4,011,000,0003,652,000,0002,971,000,000
Income Taxes Paid1,002,000,000989,000,000693,000,000
Interest Paid582,000,000396,000,000356,000,000
This is a preview of the latest data. Subscribe to access the full data.
Key Metrics
Fiscal Year202520242023
Earnings Per Share8.497.868.34
Price To Earnings Ratio41.398145.807935.9065
Earnings Growth Rate8.0153-5.755433.8684
Price Earnings To Growth Ratio5.1649-7.95911.0602
Book Value Per Share58.660454.157548.9805
Price To Book Ratio5.99166.64826.1139
Ebitda5,562,000,0005,001,000,0004,849,000,000
Enterprise Value146,179,834,000147,124,050,000123,699,016,000
Dividend Yield0.00960.00890.01
Dividend Payout Ratio0.39560.40730.3599
Debt To Equity Ratio0.70740.6590.6989
Capital Expenditures1,160,000,000856,000,000880,000,000
Free Cash Flow3,884,000,0003,386,000,0002,831,000,000
Return On Equity0.14480.14510.1702
One Year Beta0.67980.57750.8335
Three Year Beta0.69370.89410.9811
Five Year Beta0.85951.04581.0724
This is a preview of the latest data. Subscribe to access the full data.
Insider Transactions
Insider NameRelationship To IssuerTransaction DateAmount Of SecuritiesAcquired Or DisposedSecurities Owned Following Transaction
Berry William E JrVP, Chief Accounting Officer2026-03-21176D3,426
Crotty Dylan BramGroup President2026-03-21368D5,474
Wells Preston WendellVP, Chief Financial Officer2026-03-21204D6,498
Fink M KathrynVP, Chief HR Officer2026-03-21150A18,701
Fink M KathrynVP, Chief HR Officer2026-03-212,064D16,637
This is a preview of the latest data. Subscribe to access the full data.
Senate Trading
Name Of Reporting PersonType Of Reporting PersonReport DateTransaction TypeTransaction DateOwner TypeAmount
Daniel S SullivanSenator2023-07-26Sale (Full)2022-11-30Joint$1,001 - $15,000
Daniel S SullivanSenator2022-12-21Sale (Full)2022-11-30Joint$1,001 - $15,000
David A Perdue , JrSenator2021-05-02Sale (Full)2020-04-14Joint$1,001 - $15,000
David A Perdue , JrSenator2020-05-08Sale (Full)2020-04-14Joint$1,001 - $15,000
David A Perdue , JrSenator2019-11-05Sale (Partial)2019-09-30Joint$1,001 - $15,000
This is a preview of the latest data. Subscribe to access the full data.
House Trading
Name Of Reporting PersonReport DateStateTransaction TypeTransaction DateOwner TypeAmount
Thomas H. Kean2026-02-19NJ07Sale (Partial)2026-01-23—$15,001 - $50,000
Julia Letlow2026-01-13LA05Purchase2024-10-23—$1,001 - $15,000
Julia Letlow2026-01-13LA05Sale2025-10-16—$1,001 - $15,000
Gilbert Cisneros2026-01-12CA31Purchase2025-12-10—$1,001 - $15,000
Thomas H. Kean2025-12-19NJ07Sale (Partial)2025-11-20—$15,001 - $50,000
This is a preview of the latest data. Subscribe to access the full data.
Institutional Holdings
Investor NamePeriod Of ReportMarket ValueAmount Of SecuritiesPrice Per Security
ADIRONDACK TRUST CO2026-03-311,118,1323,403328.5724
Hickory Point Bank & Trust2026-03-31126,179384328.5911
Coastline Trust Co2026-03-31717,3122,183328.59
Global Wealth Strategies & Associates2026-03-319,52929328.5862
WALLER FINANCIAL PLANNING GROUP, INC2026-03-31241,704736328.4022
This is a preview of the latest data. Subscribe to access the full data.
Mutual Fund Holdings
Registrant NamePeriod Of ReportFund NameFund SymbolAmount Of UnitsValue In UsdPercentage Value Compared To Assets
Direxion Shares ETF Trust2026-01-31Direxion Daily S&P 500(R) Bull 2X ETFSPUU1,271469,710.760.2019
Direxion Shares ETF Trust2026-01-31Direxion Daily S&P 500(R) Bull 3X ETFSPXL23,9578,853,548.920.1552
Direxion Shares ETF Trust2026-01-31Direxion Daily Healthcare Bull 3X ETFCURE7,8802,912,132.81.7658
Direxion Shares ETF Trust2026-01-31Direxion HCM Tactical Enhanced US ETFHCMT2,7431,013,703.080.1737
INVESCO EXCHANGE-TRADED FUND TRUST2026-01-31Invesco S&P 500 Equal Weight ETFRSP450,852166,616,865.120.2038
This is a preview of the latest data. Subscribe to access the full data.